We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Possible Role For Newly Discovered Immune Cell Population in MS

News   Oct 26, 2020 | Original story from Thomas Jefferson University

 
Possible Role For Newly Discovered Immune Cell Population in MS
 
 
Advertisement
 

RELATED ARTICLES

New Type of Immunotherapy Developed To Fight Cancer

News

A new study reports on a new kind of immunotherapy that gives hope of more treatment options for cancer in the future.

READ MORE

Therapeutic Cancer Vaccine Demonstrates Good Safety and Efficacy in Preclinical Study

News

A checkpoint inhibitor vaccine known as PD1-Vaxx was shown to be safe and effective in a colon cancer syngeneic animal model.

READ MORE

Oxford's COVID-19 Vaccine Has 70% Efficacy Rate

News

There are now over 170 teams of researchers working to develop a vaccine for protection against COVID-19. Over the last few weeks, a number of groups shared interim analysis data on candidates that have reached Phase III clinical testing. The latest addition is the University of Oxford – in collaboration with the pharmaceutical company AstraZeneca – who today announce an efficacy of 70.4% for the candidate, ChAdOx1 nCoV-2019.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE